52
Views
0
CrossRef citations to date
0
Altmetric
Research Articles

Group B Streptococcus and Perinatality in the South of Tunisia: Epidemiology, Serotype Distribution, and Antibiotic Susceptibility

, , , , , , , & show all
Pages 21-32 | Received 16 Aug 2023, Accepted 17 Nov 2023, Published online: 08 Dec 2023

References

  • Seale AC, Bianchi-Jassir F, Russell NJ, Kohli-Lynch M, Tann CJ, Hall J, Madrid L, Blencowe H, Cousens S, Baker CJ, et al. Estimates of the burden of Group B Streptococcal disease worldwide for pregnant women, stillbirths, and children. Clin Infect Dis. 2017;65:200–19. doi:10.1093/cid/cix664.
  • Russell NJ, Seale AC, O’Driscoll M, O’Sullivan C, Bianchi-Jassir F, Gonzalez-Guarin J, Lawn JE, Baker CJ, Bartlett L, Cutland C, et al. Maternal colonization with Group B Streptococcus and serotype distribution worldwide: systematic review and meta-analyses. Clin Infect Dis. 2017;65:100–11. doi:10.1093/cid/cix658.
  • Edwards MS, Nizet V, Baker CJ. Group B Streptococcal infections. In: Remington JS, Wilson CB, Maldonado YA, Klein JO, Nizet V, editors. Infectious diseases of the fetus and newborn infant. Philadelphia (PA): Elsevier; 2011. p. 419–69.
  • Prevention of Group B Streptococcal early-onset disease in newborns: ACOG Committee Opinion Summary, Number 797. Obstet Gynecol. 2020;135:489–92.
  • Madrid L, Seale AC, Kohli-Lynch M, Edmond KM, Lawn JE, Heath PT, Madhi SA, Baker CJ, Bartlett L, Cutland C, et al. Infant Group B Streptococcal disease incidence and serotypes worldwide: systematic review and meta-analyses. Clin Infect Dis. 2017;65:S160–S72. doi:10.1093/cid/cix656.
  • WHO. Group B Streptococcus infection causes an estimated 150,000 preventable stillbirths and infant deaths every year; 2017. Available from: https://www.who.int/news/item/05-11-2017-group-b-streptococcus-infection-causes-an-estimated-150-000-preventable-stillbirths-and-infant-deaths-every-year
  • Le Doare K, O'Driscoll M, Turner K, Seedat F, Russell NJ, Seale AC, Heath PT, Lawn JE, Baker CJ, Bartlett L, et al. Intrapartum antibiotic chemoprophylaxis policies for the prevention of Group B Streptococcal disease worldwide: systematic review. Clin Infect Dis. 2017;65(suppl_2):S143–S51. doi:10.1093/cid/cix654.
  • Khatami A, Randis TM, Tavares L, Gegick M, Suzman E, Ratner AJ. Vaginal co-colonization with multiple Group B Streptococcus serotypes. Vaccine. 2019;37(3):409–11. doi:10.1016/J.VACCINE.2018.12.001.
  • Tazi A, Disson O, Bellais S, Bouaboud A, Dmytruk N, Dramsi S, Mistou MY, Khun H, Mechler C, Tardieux I, et al. The surface protein HvgA mediates Group B Streptococcus hypervirulence and meningeal tropism in neonates. J Exp Med. 2010;207(11):2313–22. doi:10.1084/jem.20092594.
  • Shabayek S, Spellerberg B. Group B Streptococcal colonization, molecular characteristics, and epidemiology. Front Microbiol. 2018;9:437. doi:10.3389/FMICB.2018.00437.
  • Poyart C, Tazi A, Tavares N, Raymond J, Trieu-Cuot P. Multiplex PCR assay for rapid and accurate capsular typing of Group B Streptococci. J Clin Microbiol. 2007;45:1985–8. doi:10.1128/JCM.00159-07.
  • Lamy M-Ć, Dramsi S, Billoe A, Couve E, Kunst F. Rapid detection of the “highly virulent” Group B Streptococcus ST-17 clone. Microbes Infect. 2006;8:1714–22. doi:10.1016/j.micinf.2006.02.008.
  • Joubrel C, Tazi A, Six A, Dmytruk N, Touak G, Bidet P, Raymond J, Trieu Cuot P, Fouet A, Kernéis S, et al. Group B Streptococcus neonatal invasive infections, France 2007–2012. Clin Microbiol Infect. 2015;21:910–6. doi:10.1016/j.cmi.2015.05.039.
  • Russell NJ, Seale AC, O’Sullivan C, Le Doare K, Heath PT, Lawn JE, Baker CJ, et al. Risk of early-onset neonatal Group B Streptococcal disease with maternal colonization worldwide: systematic review and meta-analyses. Clin Infect Dis. 2017;65:S152–S9. doi:10.1093/CID/CIX655.
  • Schrag S, Verani J. Intrapartum antibiotic prophylaxis for the prevention of perinatal Group B Streptococcal disease: experience in the United States and implications for a potential Group B Streptococcal vaccine. Vaccine. 2013;31 Suppl 4:D20–6. doi:10.1016/J.VACCINE.2012.11.056.
  • Adair CE, Kowalsky L, Quon H, Ma D, Stoffman J, McGeer A, Robertson S, Mucenski M, Davies HD. Risk factors for early-onset Group B Streptococcal disease in neonates: a population-based case-control study. Can Med Assoc J. 2003;169:198–203.
  • Cho C-Y, Tang Y-H, Chen Y-H, Wang S-Y, Yang Y-H, Wang T-H, Yeh C-C, Wu K-G, Jeng M-J. Group B Streptococcal infection in neonates and colonization in pregnant women: an epidemiological retrospective analysis. J Microbiol Immunol Infect. 2019;52(2):265–72. doi:10.1016/J.JMII.2017.08.004.
  • Shane AL, Stoll BJ. Neonatal sepsis: progress towards improved outcomes. J Infect. 2014;68 Suppl 1:S24–S32. doi:10.1016/J.JINF.2013.09.011.
  • Hannachi H, Lahmar S, Hamdoun M, Bouyahia M, Zhioua F, Bahri O. Prevalence, antimicrobial susceptibility and macrolide molecular study in vaginal Group B Streptococcus: a five-year study among pregnant women attending antenatal clinics in a tertiary care hospital in Tunisia. Res Rev Infect Dis. 2020;3:115–21. doi:10.36959/719/577.
  • Jerbi M, Hidar S, Hannachi N, El Moueddeb S, Djebbari H, Boukadida J, Chaieb A, Khairi H. Facteurs de risque du portage du Streptocoque du Groupe B chez la femme enceinte à terme : étude prospective à propos de 294 cas. Gynecol Obstet Fertil. 2007;35:312–6. doi:10.1016/j.gyobfe.2007.01.027.
  • Ferjani A, Abdallah H, Ben Saida N, Ben Gozzi C, Boukadida J. Portage vaginal du Streptocoque du Groupe B chez la femme enceinte en Tunisie : facteurs de risque et sensibilité aux antibiotiques des isolats. Bull Soc Pathol Exot. 2006;99:99–102.
  • Gizachew M, Tiruneh M, Moges F, Tessema B. Streptococcus agalactiae maternal colonization, antibiotic resistance and serotype profiles in Africa: a meta-analysis. Ann Clin Microbiol Antimicrob. 2019;18(1):14. doi:10.1186/s12941-019-0313-1.
  • Filkins L, Abmm D, Hauser J, Cm MLSA, Robinson-Dunn B, Abmm D, et al. American Society for Microbiology provides 2020 guidelines for detection and identification of Group B Streptococcus. J Clin Microbiol. 2020;59(1):e01230-20. doi:10.1128/JCM.01230-20.
  • Haimbodi EL, Mukesi M, Moyo SR. Prevalence and molecular characterization of Group B Streptococcus in pregnant women from hospitals in Ohangwena and Oshikoto regions of Namibia. BMC Microbiol. 2021;21:1–9. doi:10.1186/S12866-021-02283-2.
  • Edwards JM, Watson N, Focht C, Wynn C, Todd CA, Walter EB, Heine RP, Swamy GK. Group B Streptococcus (GBS) colonization and disease among pregnant women: a historical cohort study. Infect Dis Obstet Gynecol. 2019;2019:6. doi:10.1155/2019/5430493.
  • Chen J, Fu J, Du W, Liu X, Rongkavilit C, Huang X, Wu Y, Wang Y, McGrath E. Group B Streptococcal colonization in mothers and infants in western China: prevalences and risk factors. BMC Infect Dis. 2018;18(1):8. doi:10.1186/S12879-018-3216-4.
  • Metcalf BJ, Chochua S, Gertz RE, Hawkins PA, Ricaldi J, Li Z, Walker H, Tran T, Rivers J, Mathis S, et al. Short-read whole genome sequencing for determination of antimicrobial resistance mechanisms and capsular serotypes of current invasive Streptococcus agalactiae recovered in the USA. Clin Microbiol Infect. 2017;23:574. doi:10.1016/j.cmi.2017.02.021.
  • Puopolo KM, Lynfield R, Cummings JJ. Management of infants at risk for Group B Streptococcal disease. Pediatrics. 2019;144:e20191881. doi:10.1542/peds.2019-1881.
  • Huang J, Li S, Li L, Wang X, Yao Z, Ye X. Alarming regional differences in prevalence and antimicrobial susceptibility of Group B Streptococci in pregnant women: a systematic review and meta-analysis. J Glob Antimicrob Resist. 2016;7:169–77. doi:10.1016/J.JGAR.2016.08.010.
  • Hraoui M, Boubaker IB, Ben Rachdi M, Slim A, Ben Redjeb S. Macrolide and tetracycline resistance in clinical strains of Streptococcus agalactiae isolated in Tunisia. J Med Microbiol. 2012;61:1109–13. doi:10.1099/jmm.0.037853-0.
  • Cunha VD, Davies MR, Douarre P, Rosinski-Chupin I, Margarit I, Spinali S, Perkins T, Lechat P, Dmytruk N, Sauvage E, et al. Streptococcus agalactiae clones infecting humans were selected and fixed through the extensive use of tetracycline. Nat Commun. 2015;5:1–12. doi:10.1038/ncomms5544.
  • Bianchi-Jassir F, Paul P, To KN, Carreras-Abad C, Seale AC, Jauneikaite E, Madhi SA, Russell NJ, Hall J, Madrid L, et al. Systematic review of Group B Streptococcal capsular types, sequence types and surface proteins as potential vaccine candidates. Vaccine. 2020;38:6682–94. doi:10.1016/j.vaccine.2020.08.052.
  • Manning SD, Springman AC, Lehotzky E, Lewis MA, Whittam TS, Davies HD. Multilocus sequence types associated with neonatal Group B Streptococcal sepsis and meningitis in Canada. J Clin Microbiol. 2009;47:1143–8. doi:10.1128/JCM.01424-08.
  • Wang P, Ma Z, Tong J, Zhao R, Shi W, Yu S, Yao K, Zheng Y, Yang Y. Serotype distribution, antimicrobial resistance, and molecular characterization of invasive Group B Streptococcus isolates recovered from Chinese neonates. Int J Infect Dis. 2015;37:115–8. doi:10.1016/j.ijid.2015.06.019.
  • Gajic I, Plainvert C, Kekic D, Dmytruk N, Mijac V, Tazi A, Glaser P, Ranin L, Poyart C, Opavski N. Molecular epidemiology of invasive and non-invasive Group B Streptococcus circulating in Serbia. Int J Med Microbiol. 2019;309:19–25. doi:10.1016/J.IJMM.2018.10.005.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.